Scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
The study took place in National Institutes of Health (NIH). These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding. The study appears in the April 18, 2013, issue of Scientific Reports.
To Study Novel Coronavirus Infection NIH Scientists Develop Monkey Model
A model of infection was developed in rhesus macaques by National Institutes of Health (NIH) researchers.
Advertisement
The new coronavirus, called nCoV, was first identified in Saudi Arabia in September 2012. As of April 16, 2013, the World Health Organization has reported 17 cases with 11 deaths, primarily in the Middle East. Although the case count is small, the new coronavirus has transmitted from human-to-human in situations where people—mainly family members—have had close contact with those infected.
Because of the high fatality rate, scientists at NIH's National Institute of Allergy and Infectious Diseases (NIAID) saw an urgent need to identify therapeutic options. In laboratory tests using cells from two species of monkey, the researchers found that either ribavirin or interferon-alpha 2b, drugs currently approved for hepatitis C therapy, inhibited nCoV from replicating when used individually. However, the required drug concentrations exceeded what is recommended for people. By combining the two antivirals, the scientists established an effective treatment dose at a drug level that is achievable in people. The NIAID researchers plan to confirm these results in a recently developed monkey model of nCoV infection.
Source: Eurekalert
Source: Eurekalert
Novel Coronavirus Well-adapted to Humans, Susceptible to Immunotherapy: Study
According to a study the new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy.
Advertisement
 New Strain of Coronavirus can Infect Humans and Bats AlikeA new study published in the journal mBio reveals that public health authorities are worried over a novel strain of human coronavirus that can infect both humans and bats. | Advertisement
|
New Coronavirus Linked to Bats
A new strain of the deadly Severe Acute Respiratory Syndrome (SARS) virus has been closely related to a virus found in Asian bats, states study.
Advertisement
Recommended Readings
Latest Coronavirus News
Study highlights cardiac complications persisting in Long COVID patients: chest pain, abnormal heart rhythms.
A larger dose of dexamethasone (12 mg) appeared to be less effective than the standard dose (6 mg) for COVID-19 patients in India.
New study explores how COVID-19 vaccination might have spared a generation of American children from the enduring health challenges and expenses linked to premature birth.
Recent study reveals the immune response in adults after reducing the standard COVID-19 booster vaccine.
India's COVID case count reached 450.01 million (4.50 crore), with the administration of 2.21 billion (220.67 crore) COVID vaccine doses.